Introduction:Renal cell cancer is a chemotherapy-insensitive cancer treated by vascular endothelial growth factor receptor antagonists. Recently, a question has arisen on whether there is an interaction between tyrosine kinase inhibitors, such as sunitinib, and acid suppressing agents.
Pharmacology, Toxicology and Pharmaceutical Science
6
16%
Nursing and Health Professions
1
3%
Agricultural and Biological Sciences
1
3%
Psychology
1
3%
Other
3
8%
Unknown
14
38%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2026.
All research outputs
#4,733,758
of 32,783,667 outputs
Outputs from Journal of Oncology Pharmacy Practice
#146
of 1,726 outputs
Outputs of similar age
#39,673
of 258,554 outputs
Outputs of similar age from Journal of Oncology Pharmacy Practice
#6
of 35 outputs
Altmetric has tracked 32,783,667 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,726 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,554 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.